Development and in vitro-in vivo relationship of controlled-release microparticles loaded with tramadol hydrochloride

International Journal of Pharmaceutics

Volumn 407, Issue 1-2, 2011, Pages 38-43

  Naeem Aamir, Muhammad ^a   Ahmad, Mahmood ^a   Akhtar, Naveed ^a   Murtaza, Ghulam ^a   Khan, Shujaat Ali ^a   Shahiq Uz Zaman, ^a   Nokhodchi, Ali ^b  

^a THE ISLAMIA UNIVERSITY OF BAHAWALPUR   (Pakistan)

^b MEDWAY SCHOOL OF PHARMACY   (United Kingdom)

Author keywords

Controlled release microparticles; Ethyl cellulose; HPLC method; In vitro in vivo relationship; Tramadol

Indexed keywords

TRAMADOL;

ADULT; AREA UNDER THE CURVE; ARTICLE; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; PARTICLE SIZE; PHASE SEPARATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TIME TO MAXIMUM PLASMA CONCENTRATION; ZETA POTENTIAL;

ADMINISTRATION, ORAL; ADULT; ANALGESICS, OPIOID; AREA UNDER CURVE; CELLULOSE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; EXCIPIENTS; HALF-LIFE; HUMANS; MALE; MICROSPHERES; SOLUBILITY; TIME FACTORS; TRAMADOL; YOUNG ADULT;

EID: 79952313769     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.01.005     Document Type: Article

References (24)

1. Aysel, K., Yucel, K., 2005. Determination of tramadol hydrochloride in ampoule dosage form by using UV spectrophotometric and HPLC-DAD methods in methanol and water media. IL Farmaco. 60, 163-169.
2. Bolton, S., 1991. Correlation in Pharmaceutical Statistics: Practical and Clinical Applications. Marcel Dekker Inc., New York.
3. CDER, 2001. Guidance for the Industry, Bioanalytical Method Validation. US Department of Health and Human Services Food and Drug Administration, Centre for Drug Evaluation and Research (CDER).
4. Elena, S., Sebastian, H., Michael, K.B., Alexander, S., Inaki, F.T., 2010. Population in vitro-in vivo correlation model for pramipexole slow-release oral formulations. Pharm. Res. 27, 2.
5. Higuchi, T., 1963. Mechanism of sustained action medication, theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 52, 1145-1149.
6. Klose, D., Siepmann, F., Willart, J.F., Descamps, M., Siepmann, J., 2010. Drug release from PLGA-based microparticles: effects of the "microparticle:bulk fluid" ratio. Int. J. Pharm. 383, 123-131.
7. Korsmeyer, R.W., Gurny, R., Doelker, E., Buri, P., Peppas, N.A., 1983. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 15, 25-35.
8. Kucuk, A., Kadioglu, Y., Celebi, F., 2005. Investigation of the pharmacokinetics and determination of tramadol in rabbit plasma by a high-performance liquid chromatography-diode array detector method using liquid-liquid extraction. J. Chromatogr. B 816, 203-208. (Pubitemid 40143507)
9. Mattia, C., Coluzzi, F., 2006. Once-daily tramadol in rheumatological pain. Expert. Opin. Pharmacother. 7, 1811-1815.
10. Mendell, H.J., Dowell, J., Bigora, S., 1997. Nonlinear In vitro-In vivo Correlation. Plenum Press, New York.
11. Naeem, M.A., Mahmood, A., 2010. Production and stability evaluation of modified-release microparticles for the delivery of drug combinations. AAPS Pharm. Sci. Technol. 11, 1.
12. Musshoff, F., Madea, B., 2001. Fatality due to ingestion of tramadol alone. Forensic Sci. Int. 116, 197-199.
13. Peppas, N.A., 1985. Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta Helv. 60, 110-111.
14. Pramod, K., Sanjay, S., Brahmeshwar, M., 2009. Development and biopharmaceutical evaluation of extended release formulation of tramadol hydrochloride based on osmotic technology. Acta Pharm. 59, 15-30.
15. Ptacek, P., Macek, J., Klima, J., 2001. Rapid and simple high performance liquid hromatographic determination of nimesulide in human plasma. J. Chromatogr. B 758, 183-188. (Pubitemid 32524014)
16. Rouini, M.R., Ardakani, Y.H., Soltani, F., Aboul-Enein, H.Y., Foroumadi, A., 2006. Development and validation of rapid HPLC method for simultaneous determination of tramadol and its metabolites in human plasma. J. Chromatogr. B 830, 207-211. (Pubitemid 43075452)
17. Schug, S.A., 2003. Tramadol in acute pain. Acute Pain 5, 1-3.
18. Shinichiro, T., Taro, K., Kamada, M., Tsutomu, K., Hiroaki, N., 2010. Dosage form design and in vitro/in vivo evaluation of cevimeline extended-release tablet formulations. Int. J. Pharm. 383, 99-105.
19. Sinchaipanid, N., Pongwai, S., Limsuwan, P., Mitrevej, A., 2003. Design of salbutamol EOP tablets from pharmacokinetic parameters. Pharm. Dev. Technol. 8, 135-142.
20. United States Pharmacopoeia, 2004. In vitro and In vivo Evaluations of Dosage Forms. Mack Publishing Co, Easton, PA.
21. U.S. Department of Health and Human Services, 1997. Guidance for Industrial. Extended Release Oral Dosage Forms: Development, Evaluation and Application of In Vitro/In Vivo Correlations. Food and Drug Administration, Center for Drug Evaluation and Research (CDER).
22. Wagner, J.G., Nelson, E., 1963. Percent absorbed time plots derived from blood level and/or urinary excretion data. J. Pharm. Sci. 52, 610-611.
23. Yan, S.L., John, P.L., Gilby, E., Semali, P., Sean, P.R., 2010. The initial release of cisplatin from poly(lactide-co-glycolide) microspheres. Int. J. Pharm. 383, 244-254.
24. Zhang, L., Liu, Y., Zhongchen, W., Chen, H., 2009. Preparation and characterization of coacervate microcapsules for the delivery of antimicrobial oyster peptides. Drug Dev. Ind. Pharm. 35, 369-378.